| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 10.61B | 11.31B | 7.93B | 8.71B | -3.50B | 13.40B |
| Gross Profit | 5.75B | 11.31B | 3.70B | 3.14B | 12.00M | 4.35B |
| EBITDA | 1.78B | 1.75B | 1.61B | 1.35B | 656.00M | 1.60B |
| Net Income | 1.05B | 1.10B | 962.00M | 789.00M | 334.00M | 859.00M |
Balance Sheet | ||||||
| Total Assets | 125.85B | 122.81B | 109.86B | 93.85B | 87.42B | 94.66B |
| Cash, Cash Equivalents and Short-Term Investments | 3.02B | 1.95B | 1.57B | 1.38B | 1.36B | 1.55B |
| Total Debt | 1.50B | 2.77B | 2.09B | 1.87B | 2.07B | 1.65B |
| Total Liabilities | 117.74B | 114.54B | 102.39B | 86.81B | 80.28B | 87.41B |
| Stockholders Equity | 8.11B | 8.27B | 7.47B | 7.04B | 7.14B | 7.25B |
Cash Flow | ||||||
| Free Cash Flow | 2.76B | 3.21B | 763.00M | 1.06B | 326.00M | -63.00M |
| Operating Cash Flow | 3.02B | 3.44B | 1.04B | 1.34B | 613.00M | 185.00M |
| Investing Cash Flow | -2.01B | -2.02B | -491.00M | -307.00M | -287.00M | -294.00M |
| Financing Cash Flow | -597.00M | -712.00M | -397.00M | -1.01B | -525.00M | -294.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | C$18.05B | 13.67 | 13.19% | 3.59% | 17.16% | 22.85% | |
73 Outperform | C$5.89B | 43.97 | 14.46% | 892.19% | 5.93% | 7.86% | |
71 Outperform | C$15.31B | 24.06 | 12.80% | 2.11% | -1.40% | 14.51% | |
71 Outperform | C$54.85B | 22.52 | 12.98% | 4.11% | -10.77% | -1.88% | |
70 Outperform | C$8.30B | 10.50 | 6.52% | 0.36% | 2.88% | 32.70% | |
69 Neutral | C$8.26B | 30.75 | 11.01% | 0.98% | 24.56% | -10.00% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |